LEALI, Daria
 Distribuzione geografica
Continente #
NA - Nord America 2.275
EU - Europa 1.434
AS - Asia 1.047
SA - Sud America 178
AF - Africa 38
OC - Oceania 5
Totale 4.977
Nazione #
US - Stati Uniti d'America 2.240
PL - Polonia 502
CN - Cina 403
SG - Singapore 303
DE - Germania 275
UA - Ucraina 208
BR - Brasile 155
HK - Hong Kong 117
GB - Regno Unito 100
FI - Finlandia 70
RU - Federazione Russa 68
IT - Italia 59
VN - Vietnam 54
TR - Turchia 41
ES - Italia 36
IE - Irlanda 36
IN - India 28
FR - Francia 22
CA - Canada 20
SE - Svezia 18
BD - Bangladesh 17
CZ - Repubblica Ceca 15
IR - Iran 14
ZA - Sudafrica 12
JP - Giappone 10
ID - Indonesia 9
MX - Messico 8
KR - Corea 7
AR - Argentina 6
EG - Egitto 5
ET - Etiopia 5
MA - Marocco 5
PK - Pakistan 5
AT - Austria 4
AU - Australia 4
CO - Colombia 4
EC - Ecuador 4
IL - Israele 4
MU - Mauritius 4
NL - Olanda 4
TH - Thailandia 4
BE - Belgio 3
GE - Georgia 3
LT - Lituania 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
DZ - Algeria 2
HN - Honduras 2
IQ - Iraq 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PY - Paraguay 2
SA - Arabia Saudita 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CH - Svizzera 1
CL - Cile 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.977
Città #
Warsaw 501
Fairfield 259
Ashburn 205
Woodbridge 192
Jacksonville 158
Houston 152
Singapore 147
Ann Arbor 133
Hong Kong 110
Wilmington 106
Seattle 105
Beijing 102
Chandler 92
Cambridge 84
Princeton 64
Los Angeles 62
Nanjing 46
Dearborn 38
Helsinki 38
New York 37
Dublin 36
Madrid 30
Istanbul 29
Dallas 28
Jinan 27
Brescia 23
San Francisco 23
Dong Ket 21
Shanghai 19
Des Moines 18
Nanchang 18
Buffalo 16
Santa Clara 16
Shenyang 16
The Dalles 16
Changsha 15
São Paulo 15
Hebei 14
Jiaxing 14
Brno 13
Lancaster 13
Chicago 12
Munich 12
Stockholm 12
Ho Chi Minh City 11
Redondo Beach 11
San Mateo 11
Brooklyn 10
Moscow 10
Tokyo 10
Johannesburg 9
London 9
Phoenix 9
Hangzhou 8
Kunming 8
Nuremberg 8
Poplar 8
San Diego 8
Milan 7
Nürnberg 7
Orem 7
Rio de Janeiro 7
Jakarta 6
Kilburn 6
Montreal 6
Tianjin 6
Verona 6
Atlanta 5
Bahir Dar 5
Campinas 5
Haikou 5
Hanoi 5
Ningbo 5
Tehran 5
Zhengzhou 5
Ardabil 4
Augusta 4
Bangkok 4
Boardman 4
Denver 4
Frankfurt am Main 4
Kocaeli 4
Monmouth Junction 4
Paris 4
Toronto 4
Uberlândia 4
Ankara 3
Baliuag 3
Bengaluru 3
Brussels 3
Chennai 3
Fortaleza 3
Glasgow 3
Guangzhou 3
Leawood 3
Marigliano 3
Mauá 3
Porto Alegre 3
Rabat 3
San Jose 3
Totale 3.401
Nome #
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 303
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 290
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 265
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 241
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 230
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 208
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 203
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 195
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 191
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 188
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 186
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 181
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 158
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 154
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 132
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 128
Heparin derivatives as angiogenesis inhibitors 127
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 127
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 125
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 123
Fibroblast growth factor-2 in angiogenesis 122
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 115
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement 114
Role of inflammation in FGF2-driven angiogenesis 112
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. 111
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 97
FGF2- Antagonist activity of long pentraxin-3 97
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 96
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 93
FGF2-Antagonist activity of long pentraxin-3 related peptides 93
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 91
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 87
Cutting Edge: IL-1beta Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes 80
Totale 5.063
Categoria #
all - tutte 20.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021372 0 0 0 0 0 56 19 65 78 45 67 42
2021/2022278 6 65 2 1 1 14 16 14 10 51 23 75
2022/2023253 37 11 23 14 14 54 0 26 31 2 20 21
2023/2024333 21 38 41 17 20 26 15 12 62 13 8 60
2024/2025682 16 11 7 85 62 58 72 52 81 33 110 95
2025/2026832 142 156 103 180 238 13 0 0 0 0 0 0
Totale 5.063